Healthy Living/WellnessFDA requires testosterone products to have blood clot risk warning on labels Manufacturers of testosterone products are now required to include a general warning on labels to inform users of blood clot risks. FDA's investigation on stroke, heart attack and death risks linked with testosterone therapy is currently ongoing.by Rhodi Lee
Healthy Living/WellnessE-cigarettes remain a hot topic with lawmakers as industry growth continuesby Judy Mottl
Healthy Living/WellnessSalt reduction on the table for FDA. Current consumption at unhealthy levels, it saysby Michael McEnaney
Healthy Living/WellnessAMA lobbying for tougher e-cigarette regulations on marketing, sales of electronic smoking devicesby Judy Mottl
Healthy Living/WellnessOrexigen's Contrave diet pill awaits FDA approval, could be an obesity fighting medicineby Joseph Mayton
Healthy Living/WellnessNY lawmakers hear feedback on e-cigarette ban proposal; Senate hearing on devices Thursdayby Judy Mottl
Healthy Living/WellnessAn aspirin a day may not be so great for your health after all, says new FDA studyby Judy Mottl
Healthy Living/WellnessE-cigarettes may not be as safe as you think, new study reveals vapor carcinogenby Judy Mottl
Healthy Living/WellnessChicago ban on smoking e-cigs at indoor public spots kicks off, what state is next?by Judy Mottl
South Korea's ICT Exports Hit All-Time Growth Rate of 125.9% in April, Driven by AI Server Chip Demand